Newsletter summary

Text of news flash

[999 compound Ganmaoling out of stock arouses market suspicion] with the growth of market demandBlockchainsplitgameRecently, the supply of 999 compound Ganmaoling, which is owned by China Resources Sanjiu, falls short of demand. Practitioners of pharmacies in many places said on social platforms that the drug was often in short supply, and even some pharmacies were completely out of stock. The market's interpretation of this phenomenon is divided, and some people suspect that China Resources Sanjiu may be conducting "hunger marketing" to increase the market value of its products by restricting supply. However, in response to market suspicions, Manager Wen, the head of China Resources Sanjiu, explicitly denied the idea of bundling and hunger marketing in an interview on May 10. Manager Wen explained that the shortage was mainly due to the lack of production capacity of the drug variety. Nevertheless, the incident also reflects the tension between supply and demand in the drug market, as well as the market's sensitivity to the stability of drug supply. Although the response and explanation of China Resources Sanjiu calmed down the doubts of the market, it also revealed the challenges faced by enterprises in increasing production capacity and meeting market demand.